Creo Medical Group PLC (LON:CREO) Insider Buys £895.28 in Stock

Creo Medical Group PLC (LON:CREO) insider Christopher Paul Hancock bought 4,712 shares of the business’s stock in a transaction that occurred on Monday, January 20th. The stock was purchased at an average price of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,105.83).

Creo Medical Group Price Performance

LON:CREO opened at GBX 18 ($0.22) on Friday. Creo Medical Group PLC has a 12-month low of GBX 12 ($0.15) and a 12-month high of GBX 43 ($0.53). The firm has a market capitalization of £65.12 million, a price-to-earnings ratio of -300.00 and a beta of 0.86. The stock’s 50 day moving average price is GBX 17.56 and its two-hundred day moving average price is GBX 23.36. The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.